Publications by authors named "Dianhe Li"

Claim this Profile
A
An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report.
Senmiao Huang, Dianhe Li, Yongye Huang, Guojie Lu, Ying Tian, Mengli Huang

Front Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors' combination therapy as first-line treatment in advanced esophageal squamous cell carcinoma: a meta-analysis.
Dianhe Li, Ling Tang, Jiazhu Hu, Xiaolong Cao, Yan He

J Cancer Res Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer.
Xiaotong Duan, Simiao Qiao, Dianhe Li, Shangbiao Li, Zhihao Zheng

Front Genet· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma.
Cheng-Ya Dong, Jiayue Cui, Dian-He Li, Qi Li, Xin-Yu Hong

Oncol Rep· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of oligometastatic non-small cell lung cancer: a meta-analysis.
Shangbiao Li, Rui Zhu, Dianhe Li, Na Li, Xiaoxia Zhu

J Thorac Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of postoperative radiotherapy on outcome in resectable stage IIIA-N2 non-small-cell lung cancer: an updated meta-analysis.
Nazmus Sakib, Na Li, Xiaoxia Zhu, Dianhe Li, Yiyi Li

Nucl Med Commun· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysis.
Dianhe Li, Xiaoxia Zhu, Haofei Wang, Min Qiu, Na Li

J Thorac Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of radiotherapy for neck carcinoma metastasis from unknown primary sites: a meta-analysis.
Xiaomei Liu, Dianhe Li, Na Li, Xiaoxia Zhu

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism.
Zhou Sha, Xiaoxia Zhu, Na Li, Yiyi Li, Dianhe Li

Oncotarget· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials.
Min Ying, Xiao-Xia Zhu, Yang Zhao, Dian-He Li, Long-Hua Chen

Asian Pac J Cancer Prev· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
Hong Zhang, Xiaoxia Zhu, Na Li, Dianhe Li, Zhou Sha

Acta Biochim Biophys Sin (Shanghai)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.
Yuan Fang, Xiaoxia Zhu, Jian Wang, Na Li, Dianhe Li

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis